REGN icon

Regeneron Pharmaceuticals

657 hedge funds and large institutions have $23.1B invested in Regeneron Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 242 increasing their positions, 258 reducing their positions, and 111 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

less call options, than puts

Call options by funds: $ | Put options by funds: $

24% less capital invested

Capital invested by funds: $30.4B → $23.1B (-$7.27B)

42% less first-time investments, than exits

New positions opened: 64 | Existing positions closed: 111

55% less funds holding in top 10

Funds holding in top 10: 115 (-6)

Holders
657
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$507M
Puts
$646M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.54B
2
$1.9B
3
$1.89B
4
$1.23B
5
$1.09B
6
$1.03B
7
$1B
8
$557M
9
$496M
10
$478M
11
$475M
12
$421M
13
$363M
14
$356M
15
$323M
16
$306M
17
$304M
18
$256M
19
$252M
20
$229M
21
$216M
22
$213M
23
$196M
24
$190M
25
$189M